background
hospitalacquir
pneumonia
aris
nonventil
patient
nvhap
tradit
thought
caus
bacteria
littl
known
viral
etiolog
syndrom
sought
describ
preval
virus
caus
nvhap
determin
factor
independ
associ
isol
viru
method
identifi
patient
nvhap
one
year
review
cultur
determin
etiolog
patient
viral
process
compar
either
neg
cultur
bacteri
infect
determin
variabl
independ
associ
recoveri
viru
result
among
case
cultur
posit
virus
identifi
bacteri
pathogen
aros
subject
common
virus
includ
rhinoviru
influenza
parainfluenza
note
season
isol
viral
organ
case
viral
nvhap
develop
week
length
stay
lo
outcom
viral
nvhap
similar
bacteri
nvhap
patient
viral
bacteri
nvhap
gener
similar
two
variabl
independ
associ
isol
viru
histori
coronari
arteri
diseas
adjust
odd
ratio
ci
lo
greater
day
prior
nvhap
diagnosi
adjust
odd
ratio
ci
screen
test
viru
neither
good
sensit
specif
conclus
virus
repres
common
caus
nvhap
clinician
consid
viral
diagnost
test
nvhap
may
repres
mean
enhanc
antimicrobi
stewardship
nosocomi
pneumonia
np
remain
import
hospitalacquir
complic
result
substanti
morbid
mortal
compris
ventilatorassoci
pneumonia
vap
hospitalacquir
pneumonia
hap
aris
nonventil
subject
np
focu
multipl
qualiti
effort
hospit
across
globe
major
research
np
dealt
vap
mainli
patient
risk
vap
easi
identifi
given
locat
intens
care
unit
icu
less
known
hap
aris
nonventil
patient
nvhap
thu
conclus
base
studi
conduct
vap
often
gener
nvhap
howev
pool
person
risk
nvhap
substanti
larger
cohort
risk
vap
rel
small
proport
hospit
patient
undergo
mechan
ventil
mv
may
develop
vap
vast
major
subject
hospit
never
requir
mv
therefor
need
inform
regard
nvhap
particularli
relat
microbiolog
outcom
nvhap
tradit
case
pneumonia
hospit
whether
communityacquir
pneumonia
cap
hap
vap
thought
caus
bacteri
pathogen
role
viral
organ
pneumonia
histor
felt
mainli
issu
immunosuppress
transplant
popul
recent
analys
though
underscor
signific
virus
import
caus
pneumonia
exampl
jain
colleagu
multicent
observ
studi
hospit
cap
note
virus
preval
caus
infect
bacteria
similarli
investig
implic
viral
organ
major
caus
vap
hong
et
al
isol
virus
vap
case
despit
grow
appreci
signific
virus
variou
form
pneumonia
studi
yet
describ
role
virus
nvhap
appreci
import
virus
nvhap
could
prove
import
facilit
develop
tool
might
foster
antibiot
stewardship
exampl
principl
antibiot
deescal
would
demand
discontinu
antibacteri
nonbacteri
pathogen
identifi
etiolog
agent
therefor
conduct
retrospect
analysi
patient
nvhap
determin
preval
virus
syndrom
describ
characterist
person
viral
infect
addit
sought
determin
one
could
identifi
patient
like
viral
etiolog
oppos
bacteri
one
base
patient
characterist
studi
retrospect
analysi
person
diagnos
nvhap
singl
year
singl
center
prior
aspect
analysi
describ
elsewher
briefli
studi
conduct
januari
decemb
includ
adult
age
year
admit
hospit
least
h
exclud
subject
transfer
healthcar
facil
person
requir
mv
subsequ
extuabt
h
prior
onset
new
pneumonia
word
exclud
vap
process
like
evolv
patient
mv
subject
need
mv
support
nvhap
enrol
patient
suffer
multipl
episod
nvhap
first
instanc
includ
studi
retrospect
hospit
institut
review
board
waiv
need
inform
consent
irb
recoveri
viral
pathogen
serv
primari
endpoint
studi
defin
nvhap
accord
american
thorac
societi
posit
statement
np
subject
screen
potenti
diagnosi
nvhap
base
order
respiratori
cultur
initi
h
hospit
subsequ
chest
imag
identifi
potenti
case
review
one
investig
mhk
ensur
new
progress
infiltr
infiltr
fact
aris
h
hospit
eg
present
admiss
addit
radiograph
result
ensur
presenc
pneumonia
case
requir
meet
least
meet
two
follow
criteria
fever
greater
c
hypothermia
leukocytosi
leukopenia
purul
respiratori
secret
find
respiratori
cultur
classifi
reveal
either
viral
bacteri
organ
cultur
neg
addit
blood
cultur
potenti
respiratori
cultur
review
patient
requir
mv
result
nvhap
includ
sputum
bronchoalveolar
lavag
bal
subject
requir
mv
onset
respiratori
failur
complic
nvhap
also
examin
cultur
tracheal
aspir
blind
balsso
long
obtain
within
h
onset
mv
nvhap
determin
result
varieti
viral
diagnost
techniqu
includ
qualit
nucleic
acid
test
respiratori
virus
select
bacteri
pathogen
filmarray
respiratori
panel
biofir
diagnost
inc
salt
lake
citi
utah
standard
practic
studi
instittuion
obtain
viral
panel
patient
suspect
pneumonia
irrespect
whether
ventil
furthermor
patient
unabl
provid
specimen
nasopharyng
swab
obtain
decis
regard
order
initi
respiratori
cultur
undertaken
patient
primari
clinic
team
guid
formal
protocol
record
patient
demograph
characterist
along
comorbid
ill
coronari
arteri
diseas
cad
congest
heart
failur
chf
chronic
obstruct
pulmonari
diseas
copd
other
calcul
charlson
comorbid
score
patient
captur
global
burden
chronic
ill
also
note
durat
hospit
lo
prior
nvhap
onset
whether
subject
requir
icu
care
week
prior
nvhap
respect
outcom
determin
patient
die
hospit
lo
nvhap
diagnosi
determin
variabl
independ
associ
viral
etiolog
nvhap
specif
compar
viral
pathogen
remain
subject
either
organ
identifi
bacteri
pathogen
diagnos
compar
categor
variabl
fisher
exact
test
continu
variabl
either
student
ttest
mann
whitney
u
test
appropri
comparison
continu
variabl
across
three
potenti
cohort
viral
bacteri
cultureneg
analyz
via
anova
data
parametr
distribut
data
nonparametr
natur
employ
kruskalw
test
test
two
tail
p
valu
consid
repres
statist
signific
determin
factor
independ
associ
recoveri
viral
etiolog
reli
logist
regress
regress
stepwis
backward
approach
enter
variabl
signific
level
univari
analysi
model
variabl
assess
colinear
assess
good
fit
hosmerlemeshow
hl
test
adjust
odd
ratio
aor
confid
interv
ci
present
appropri
final
cohort
includ
case
mean
age
year
male
cultur
posit
case
virus
identifi
patient
note
bacteri
pathogen
subject
crude
hospit
mortal
correl
type
pathogen
caus
infect
common
viral
organ
rhinoviru
n
influenza
n
parainfluenza
n
coronaviru
n
metapneumoviru
rhinoviru
n
frequent
bacteri
pathogen
staphylococcu
aureu
n
pseudomona
aeruginosa
n
although
influenza
aros
often
tradit
influenza
season
north
america
season
seen
distribut
viral
organ
tabl
reveal
differ
cultur
neg
patient
either
viral
bacteri
etiolog
patient
virus
like
care
icu
week
prior
nvhap
onset
differ
approach
statist
signific
cad
less
preval
patient
viral
infect
variabl
charlson
score
lo
prior
nvhap
signific
differ
among
subject
function
result
respiratori
cultur
tabl
show
result
bivari
comparison
posit
viral
find
other
nvhap
gener
comparison
across
three
strata
possibl
cultur
result
differ
cad
less
preval
viral
etiolog
nvhap
neither
distribut
comorbid
charlson
score
vari
base
cultur
find
also
differ
base
whether
patient
undergon
surgeri
hospit
requir
icu
care
prior
pneumonia
diagnosi
viru
identifi
respons
infect
hospit
longer
without
etiolog
day
vs
day
differ
approach
statist
signific
howev
person
viral
nvhap
twice
like
requir
prolong
hospit
eg
day
nvhap
develop
vs
p
differ
outcom
eg
hospit
mortal
lo
nvhap
readmiss
base
whether
viru
recov
two
variabl
independ
associ
isol
viru
base
logist
regress
person
histori
cad
approxim
time
like
viral
etiolog
aor
ci
p
although
cad
occur
infrequ
among
viral
pathogen
variabl
remain
associ
viral
infect
mani
variabl
enter
model
colinear
cad
becam
signific
part
stepwis
elimin
process
addit
lo
greater
day
prior
nvhap
diagnosi
correl
recoveri
viru
aor
ci
final
model
good
fit
base
hl
p
valu
screen
test
isol
viru
nvhap
neither
factor
combin
good
sensit
specif
predict
eventu
result
cultur
retrospect
analysi
demonstr
virus
commonli
isol
nvhap
bacteri
organ
virus
appear
lead
similar
degre
morbid
mortal
compar
bacteria
infect
patient
characterist
readili
distinguish
person
infect
bacteri
organ
oppos
viru
import
virus
cap
long
establish
especi
influenza
season
howev
signific
virus
influenza
cap
recent
confirm
larg
epidemiolog
studi
hospit
cap
addit
show
virus
frequent
recov
bacteria
jain
et
al
document
viral
pathogen
influenza
seen
cap
document
similar
cap
nvhap
rang
viral
organ
isol
syndrom
includ
parainfluenza
viru
metapneumoviru
coronaviru
choi
cowork
analysi
includ
cap
healthcareassoci
pneumonia
hcap
establish
central
role
virus
pneumonia
syndrom
requir
hospit
strikingli
third
hcap
form
np
infect
viru
accord
find
choi
et
al
investig
separ
studi
confirm
viral
organ
could
also
found
person
suffer
vap
among
cohort
person
vap
infect
caus
viru
common
virus
vap
respiratori
syncyti
viru
parainfluenza
viru
studi
build
earlier
report
reveal
virus
major
caus
anoth
form
np
case
nvhap
prior
work
expressli
focus
role
virus
nvhap
furthermor
littl
inform
exist
gener
describ
microbiolog
nvhap
therefor
find
import
help
confirm
etiolog
agent
vap
gener
similar
nvhap
result
also
indic
search
viral
etiolog
nvhap
prudent
especi
bacteri
cultur
unrev
although
select
clinic
variabl
occur
commonli
person
viral
caus
nvhap
relianc
factor
either
reliabl
includ
exclud
presenc
bacteri
pathogen
imprud
characterist
identifi
independ
link
isol
viru
still
occur
commonli
subject
bacteri
infect
addit
independ
associ
note
clinic
featur
isol
viral
pathogen
lack
clear
biolog
plausibl
explain
potentian
connect
eg
relationship
cad
viral
pathogen
therefor
find
much
interpret
caution
thu
clinician
continu
empir
treat
patient
diagnos
nvhap
antibiot
pend
result
cultur
guid
antibiot
deescal
hand
ad
search
viral
organ
routin
cultur
might
facilit
antibiot
discontinu
viru
eventu
identifi
bacteri
cultur
remain
neg
antibiot
like
discontinu
given
preval
viru
nvhap
note
potenti
limit
antibiot
prescrib
may
substanti
similarli
rel
high
frequenc
viru
note
nvhap
along
result
studi
note
cap
vap
suggest
effort
develop
rapid
diagnost
microbiolog
test
respiratori
infect
need
includ
test
viral
etiolog
failur
might
result
subject
remain
antibiot
longer
truli
benefit
studi
number
limit
first
repres
retrospect
effort
thu
prone
multipl
form
bia
specif
fact
viral
test
systemat
undertaken
case
suggest
viral
infect
certainli
miss
henc
may
actual
underestim
preval
viral
organ
syndrom
second
bacteri
viral
diagnost
test
cultur
imperfect
patient
actual
infect
either
type
pathogen
might
misclassifi
cultur
neg
fact
infect
aris
either
viru
bacterium
third
although
order
viral
panel
routin
suspect
pneumonia
studi
hospit
qualiti
specimen
obtain
certainli
vari
patient
abl
expector
sputum
could
analyz
may
led
underestim
preval
select
pathogen
use
nasopharyng
swab
patient
unabl
provid
sputum
howev
mitig
degre
impact
factor
fourth
fail
note
mix
viral
bacteri
infect
infect
multipl
virus
observ
along
point
reinforc
concern
specimen
may
inadequ
patient
diagnost
purpos
particularli
bacteri
cultur
inabl
review
lower
airway
cultur
patient
necessari
limit
effort
understand
pneumonia
nonventil
patient
fifth
find
deriv
singl
larg
academ
hospit
thu
generaliz
observ
certainli
limit
taken
hole
multipl
limit
demonstr
result
need
view
hypothesi
gener
need
confirm
conclus
virus
seem
caus
substanti
proport
case
nvahp
virus
involv
nvhap
potenti
divers
multipl
potenti
bacteri
etiolog
infect
physician
consid
expand
test
viral
etiolog
patient
diagnos
nvhap
conflict
interest
support
dr
kollef
work
support
bjc
healthcar
foundat
potenti
conflict
interest
dr
shorr
receiv
research
support
serv
consult
speaker
abbott
alio
allergam
astella
astrazeneca
bayer
cidara
medco
melinta
merck
paratek
roch
tetraphas
therav
wockhardt
dr
zilberberg
serv
consult
receiv
research
support
astella
medco
melinta
tetraphas
therav
neither
receiv
extramur
support
conduct
studi
note
direct
conflict
rel
paper
